| 2026-05-05 |
详情>>
股本变动：
变动后总股本54017.70万股
|
| 2026-05-05 |
详情>>
业绩披露：
2026年一季报每股收益0.43欧元,归母净利润1.18亿欧元,同比去年增长-22.28%
|
| 2026-04-14 |
股东大会：
将于2026-05-21召开股东大会
会议内容 ▼▲
- 1.Agenda
2.Presentation of the adopted annual financial statements and the approved consolidated financial statements, the management reports for Fresenius Medical Care AG and the group, the explanatory report by the Management Board on the information pursuant to Sections 289a, 315a of the German Commercial Code (Handelsgesetzbuch) and the report by the Supervisory Board of Fresenius Medical Care AG for fiscal year 2025
3.Resolution on the allocation of distributable profit
4.Resolution on the approval of the actions of the members of the Management Board of Fresenius Medical Care AG for fiscal year 2025
5.Resolution on the approval of the actions of the members of the Supervisory Board of Fresenius Medical Care AG for fiscal year 2025
6.Election of the auditor and group auditor for fiscal year 2026, the auditor of the sustainability reporting for fiscal year 2026 as well as the auditor for the potential review of the half-year financial report for fiscal year 2026 and other interim financial information
7.Resolution on the approval of the compensation report for fiscal year 2025
8.Resolution on the authorization to purchase and use treasury shares pursuant to Section 71(1) No. 8 AktG and on the exclusion of subscription rights
|
| 2026-02-24 |
详情>>
业绩披露：
2023年年报每股收益1.70欧元,归母净利润4.99亿欧元,同比去年增长-25.9%
|
| 2026-02-24 |
详情>>
业绩披露：
2025年年报每股收益3.36欧元,归母净利润9.78亿欧元,同比去年增长81.88%
|
| 2026-02-24 |
财报披露：
美东时间 2026-02-24 盘前发布财报
|
| 2025-11-04 |
详情>>
业绩披露：
2025年三季报(累计)每股收益2.22欧元,归母净利润6.51亿欧元,同比去年增长38.27%
|
| 2025-08-05 |
详情>>
业绩披露：
2025年中报每股收益1.28欧元,归母净利润3.76亿欧元,同比去年增长45.93%
|
| 2025-05-06 |
详情>>
业绩披露：
2025年一季报每股收益0.52欧元,归母净利润1.51亿欧元,同比去年增长113.11%
|
| 2025-04-10 |
股东大会：
将于2025-05-22召开股东大会
会议内容 ▼▲
- 1.Presentation of the adopted annual financial statements and the approved consolidated financial statements, the management reports for Fresenius Medical Care AG and the group, the explanatory report by the Management Board on the information pursuant to sec. 289a, 315a of the German Commercial Code (Handelsgesetzbuch) and the report by the Supervisory Board of Fresenius Medical Care AG for fiscal year 2024.
2.Resolution on the allocation of distributable profit.
3.Resolution on the approval of the actions of the members of the Management Board of Fresenius Medical Care AG for fiscal year 2024.
4.Resolution on the approval of the actions of the members of the Supervisory Board of Fresenius Medical Care AG for fiscal year 2024.
5.Election of the auditor and group auditor for fiscal year 2025, the auditor of the sustainability reporting for fiscal year 2025 as well as the auditor for the potential review of the half-year financial report for fiscal year 2025 and other interim financial information.
6.Resolution on the approval of the compensation report for fiscal year 2024.
7.Resolution on the cancellation of the existing authorized capitals, on the creation of a new authorized capital including the possibility of the exclusion of subscription rights as well as on corresponding amendments to Article 4 (3) and (4) of the Articles of Association of the Company.
8.Resolution on the granting of an authorization to issue convertible bonds and/or bonds with warrants with the option of excluding subscription rights, on the creation of a Conditional Capital 2025 and on the corresponding amendment to the Articles of Association of the Company.
9.Resolution on a new authorization of the Management Board to provide for the holding of a virtual General Meeting and on the corresponding amendment to Article 15 (3) of the Articles of Association of the Company.
10.Resolution on an amendment to Article 10 (6) of the Articles of Association of the Company (language version of the minutes of the Supervisory Board).
|
| 2025-02-25 |
详情>>
业绩披露：
2024年年报每股收益1.83欧元,归母净利润5.38亿欧元,同比去年增长7.80%
|
| 2025-02-25 |
详情>>
业绩披露：
2022年年报每股收益2.30欧元,归母净利润6.73亿欧元,同比去年增长-30.53%
|
| 2024-11-05 |
详情>>
业绩披露：
2024年三季报(累计)每股收益1.61欧元,归母净利润4.71亿欧元,同比去年增长51.42%
|
| 2024-07-30 |
详情>>
业绩披露：
2024年中报每股收益0.88欧元,归母净利润2.58亿欧元,同比去年增长13.79%
|
| 2024-05-07 |
详情>>
业绩披露：
2024年一季报每股收益0.24欧元,归母净利润7095.90万欧元,同比去年增长-17.84%
|
| 2024-03-28 |
股东大会：
将于2024-05-16召开股东大会
会议内容 ▼▲
- 1.Presentation of the adopted annual financial statements and the approved con-solidated financial statements, the management reports for Fresenius MedicalCare AG and the group, the explanatory report by the Management Board on theinformation pursuant to sec. 289a, 315a of the German Commercial Code (Han-delsgesetzbuch) and the report by the Supervisory Board of Fresenius MedicalCare AG for fiscal year 2023.
2.Resolution on the allocation of distributable profit.
3.Resolution on the approval of the actions of the former General Partner FreseniusMedical Care Management AG for fiscal year 2023.
4.Resolution on the approval of the actions of the members of the ManagementBoard of Fresenius Medical Care AG for fiscal year 2023.
5.Resolution on the approval of the actions of the members of the SupervisoryBoard of Fresenius Medical Care AG & Co. KGaA for fiscal year 2023.
6.Resolution on the approval of the actions of the members of the Supervisory
Board of Fresenius Medical Care AG for fiscal year 2023.
7.Election of the auditor and group auditor for fiscal year 2024, the auditor of thesustainability reporting for fiscal year 2024 as well as the auditor for the potentialreview of the half-year financial report for fiscal year 2024 and other interim finan-cial information.
8.Resolution on the approval of the compensation report for fiscal year 2023.
9.Resolution on the approval of the compensation system for the members of the Management Board.
10.Resolution on the remuneration of the members of the Supervisory Board as wellas a corresponding amendment of Article 14 of the Articles of Association of the Company.
11.Resolution on an amendment of Article 16 (1) of the Articles of Association of the Company (Attendance at the General Meeting and Exercise of the Voting Right)due to an amendment of the German Stock Corporation Act.
|
| 2022-03-30 |
股东大会：
将于2022-05-12召开股东大会
会议内容 ▼▲
- 1.Presentation of the annual financial statements and consolidated financial statements each approved by the Supervisory Board, the management reports for Fresenius Medical Care AG & Co. KGaA and the group, the explanatory report by the General Partner on the information pursuant to sections 289a, 315a of the German Commercial Code (Handelsgesetzbuch – HGB) and the report by the Supervisory Board of Fresenius Medical Care AG & Co. KGaA for fiscal year 2021; resolution on the approval of the annual financial statements of Fresenius Medical Care AG & Co. KGaA for fiscal year 2021
2.Resolution on the allocation of distributable profit
3.Resolution on the approval of the actions of the General Partner for fiscal year 2021
4.Resolution on the approval of the actions of the Supervisory Board for fiscal year 2021
5.Election of the auditor and group auditor for fiscal year 2022 as well as the auditor for the potential review of the half year financial report for fiscal year 2022 and other interim financial information
6.Resolution on the approval of the compensation report for fiscal year 2021
|
| 2021-09-06 |
温馨提示：
美股因劳工节，9月6日休市一天
|
| 2021-05-03 |
股东大会：
将于2021-05-20召开股东大会
会议内容 ▼▲
- 1.Presentation of the annual financial statements and consolidated financial statements each approved by the Supervisory Board, the management reports for Fresenius Medical Care AG & Co. KGaA and the group, the explanatory report by the General Partner on the information pursuant to sections 289a, 315a of the German Commercial Code (Handelsgesetzbuch – HGB) and the report by the Supervisory Board of Fresenius Medical Care AG & Co. KGaA for fiscal year 2020; resolution on the approval of the annual financial statements of Fresenius Medical Care AG & Co. KGaA for fiscal year 2020
2.Resolution on the allocation of distributable profit
3.Resolution on the approval of the actions of the General Partner for fiscal year 2020
4.Resolution on the approval of the actions of the Supervisory Board for fiscal year 2020
5.Election of the auditor and group auditor for fiscal year 2021 as well as the auditor for the potential review of the half year financial report for fiscal year 2021 and other interim financial information
6.Elections to the Supervisory Board and to the Joint Committee
7.Resolution on the authorization to purchase and use treasury shares pursuant to section 71 (1) no. 8 AktG and on the exclusion of subscription rights
|
| 2020-07-17 |
股东大会：
将于2020-08-27召开股东大会
会议内容 ▼▲
- 1.Presentation of the annual financial statements and consolidated group financial statements each approved by the Supervisory Board, the management reports for Fresenius Medical Care AG & Co. KGaA and the consolidated group, the explanatory report by the General Partner on the information pursuant to sections 289a, 315a of the German Commercial Code (Handelsgesetzbuch — HGB) and the report by the Supervisory Board of Fresenius Medical Care AG & Co. KGaA for fiscal year 2019; resolution on the approval of the annual financial statements of Fresenius Medical Care AG & Co. KGaA for fiscal year 2019
2.Resolution on the allocation of distributable profit
3.Resolution on the approval of the actions of the General Partner for fiscal year 2019
4.Resolution on the approval of the actions of the Supervisory Board for fiscal year 2019
5.Election of the auditor and consolidated group auditor for fiscal year 2020 as well as the auditor for the potential review of interim financial information
6.Resolution on the approval of the compensation system for the members of the Management Board of the General Partner
7.Resolution on the remuneration of the members of the Supervisory Board and on the amendment of Article 13 and Article 13e (3) of the Articles of Association
8.Resolution on the cancellation of the existing authorized capitals, on the creation of new authorized capitals including the possibility of the exclusion of subscription rights as well as on corresponding amendments to Article 4 (3) and (4) of the Articles of Association of the Company
9.Resolution on the amendment of Article 15 (1) sentence 2 of the Company’s Articles of Association (Alignment with the German Stock Corporation Act as amended by the ARUG II)
|
| 2019-04-10 |
股东大会：
将于2019-05-16召开股东大会
会议内容 ▼▲
- 1.Presentation of the annual financial statements and consolidated group financial statements each approved by the Supervisory Board, the management reports for Fresenius Medical Care AG & Co. KGaA and the consolidated group, the explanatory report by the General Partner on the information pursuant to sections 289a (1), 315a (1) of the German Commercial Code (Handels-gesetzbuch - HGB) and the report by the Supervisory Board of Fresenius Medical Care AG & Co. KGaA for fiscal year 2018; resolution on the approval of the annual financial statements of Fresenius Medical Care AG & Co. KGaA for fiscal year 2018
2.Resolution on the allocation of distributable profit
3.Resolution on the approval of the actions of the General Partner for fiscal year 2018
4.Resolution on the approval of the actions of the Supervisory Board for fiscal year 2018
5.Election of the auditor and consolidated group auditor as well as the auditors for the potential review of the first half year financial report and other interim financial information
6.Elections to the Supervisory Board
|
| 2018-05-10 |
除权日：
美东时间 2018-05-21 每股派息0.43美元
|
| 2018-04-19 |
股东大会：
将于2018-05-17召开股东大会
会议内容 ▼▲
- 1.Presentation of the annual financial statements and consolidated group financial statements each approved by the Supervisory Board, the management reports for Fresenius Medical Care AG & Co. KGaA and the consolidated group, the explanatory report by the General Partner on the information pursuant to sections 289a (1), 315a (1) of the German Commercial Code (Handelsgesetzbuch - HGB) and the report by the Supervisory Board of Fresenius Medical Care AG & Co. KGaA for fiscal year 2017; resolution on the approval of the annual financial statements of Fresenius Medical Care AG & Co. KGaA for fiscal year 2017
2.Resolution on the allocation of distributable profit
3.Resolution on the approval of the actions of the General Partner for fiscal year 2017
4.Resolution on the approval of the actions of the Supervisory Board for fiscal year 2017
5.Election of the auditor and consolidated group auditor for fiscal year 2018
6.Modernization and revision of various provisions of the Articles of Association
|
| 2017-04-21 |
除权日：
美东时间 2017-05-11 每股派息0.37美元
|
| 2017-04-11 |
股东大会：
将于2017-05-11召开股东大会
会议内容 ▼▲
- 1.Presentation of the annual financial statements and consolidated group financial statements each approved by the Supervisory Board, the management reports for Fresenius Medical Care AG & Co. KGaA and the consolidated group, the explanatory report by the General Partner on the information pursuant to sections 289 (4), 315 (4) of the German Commercial Code (Handelsgesetzbuch - HGB) and the report of the Supervisory Board of Fresenius Medical Care AG & Co. KGaA for fiscal year 2016; resolution on the approval of the annual financial statements of Fresenius Medical Care AG & Co. KGaA for fiscal year 2016
2.Resolution on the allocation of distributable profit
3.Resolution on the approval of the actions of the General Partner for fiscal year 2016
4.Resolution on the approval of the actions of the Supervisory Board for fiscal year 2016
5.Election of the auditor and consolidated group auditor for fiscal year 2017
|
| 2016-05-16 |
除权日：
美东时间 2016-05-10 每股派息0.31美元
|
| 2015-05-08 |
除权日：
美东时间 2015-05-15 每股派息0.44美元
|
| 2014-05-01 |
除权日：
美东时间 2014-05-13 每股派息0.53美元
|
| 2013-05-06 |
除权日：
美东时间 2013-05-14 每股派息0.49美元
|
| 2012-04-25 |
除权日：
美东时间 2012-05-08 每股派息0.91美元
|
| 2011-04-26 |
除权日：
美东时间 2011-05-10 每股派息0.95美元
|